SCHEMBL28522211

SCHEMBL28522211

Cc1ccc(S(=O)(=O)OCP(=O)(Oc2ccccc2)Oc2ccccc2)cc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 5/20 0.54
KMT2A Q03164 5/20 0.54
ALDH1A1 P00352 1/20 0.54
FFAR1 O14842 1/20 0.47
HTT P42858 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
LMNA P02545 3/20 0.44
CA12 O43570 2/20 0.44
CA1 P00915 2/20 0.44
CA2 P00918 2/20 0.44
CA9 Q16790 2/20 0.44
AR P10275 1/20 0.42
MAPT P10636 1/20 0.41
NPSR1 Q6W5P4 2/20 0.40
GAA P10253 1/20 0.40
VDR P11473 1/20 0.40
CYP3A4 P08684 1/20 0.40
TSHR P16473 1/20 0.40
STAT3 P40763 1/20 0.39
CA4 P22748 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16283692 0.86 MEN1 (0.51) MEN1KMT2AALDH1A1FFAR1HTT
SCHEMBL28514304 0.85 MEN1 (0.54) MEN1KMT2AALDH1A1LMNACA12
SCHEMBL28513058 0.82 MEN1 (0.48) MEN1KMT2AALDH1A1HTTSMN1; SMN2
SCHEMBL16020645 0.80 MAPT (0.44) MEN1KMT2AALDH1A1LMNACA12
SCHEMBL8871679 0.80 STAT3 (0.43) KMT2AALDH1A1HTTSMN1; SMN2LMNA
SCHEMBL1866694 0.79 ALDH1A1 (0.46) MEN1KMT2AALDH1A1HTTSMN1; SMN2
SCHEMBL27193057 0.78 MEN1 (0.49) MEN1KMT2AALDH1A1FFAR1HTT
SCHEMBL139911 0.77 CA12 (0.41) MEN1KMT2AALDH1A1CA12CA1
SCHEMBL8673256 0.77 MEN1 (0.57) MEN1KMT2AALDH1A1FFAR1HTT
SCHEMBL23703227 0.76 GAA (0.43) MEN1KMT2AALDH1A1HTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4662219-A2 PRODRUGS OF THYROID HORMONE ANALOGS, METHODS OF MAKING AND METHODS OF USING THEREOF ASCLETIS PHARMA (CHINA) CO., LIMITED (HK) 2025-12-17 EP disclosed
US-20240294561-A1 Prodrugs of Thyroid Hormone Analogs, Methods of Making and Methods of Using Thereof ASCLETIS PHARMA (CHINA) CO., LIMITED (CN) 2024-09-05 US disclosed
WO-2024167961-A2 PRODRUGS OF THYROID HORMONE ANALOGS, METHODS OF MAKING AND METHODS OF USING THEREOF GANNEX, LLC (US) 2024-08-15 WO disclosed
CN-115677774-A Phosphonate derivatives, their preparation and use 上海医药工业研究院有限公司 2023-02-03 CN disclosed
CN-114409706-A Preparation method of phenyl hydrogen phosphonate and intermediate thereof 上海医药工业研究院 2022-04-29 CN disclosed
CN-112175003-B Preparation method of phenyl hydrogen phosphonate and intermediate thereof 上海医药工业研究院 2022-02-15 CN disclosed
CN-112175003-A Preparation method of phenyl hydrogen phosphonate and intermediate thereof 上海医药工业研究院 2021-01-05 CN disclosed
CN-108409788-B Preparation method of tenofovir alafenamide fumarate 科兴生物制药股份有限公司 2020-05-08 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240294561-A1 Prodrugs of Thyroid Hormone Analogs, Methods of Making and Methods of Using Thereof THRB, THRA, TSHR MEN1 712/4885KMT2A 2974/4885ALDH1A1 1710/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.